» Articles » PMID: 2169613

Structural Design and Molecular Evolution of a Cytokine Receptor Superfamily

Overview
Specialty Science
Date 1990 Sep 1
PMID 2169613
Citations 383
Authors
Affiliations
Soon will be listed here.
Abstract

A family of cytokine receptors comprising molecules specific for a diverse group of hematopoietic factors and growth hormones has been principally defined by a striking homology of binding domains. This work proposes that the approximately 200-residue binding segment of the canonical cytokine receptor is composed of two discrete folding domains that share a significant sequence and structural resemblance. Analogous motifs are found in tandem approximately 100-amino acid domains in the extracellular segments of a receptor family formed by the interferon-alpha/beta and -gamma receptors and tissue factor, a membrane tether for a coagulation protease. Domains from the receptor supergroup reveal clear evolutionary links to fibronectin type III structures, approximately 90-amino acid modules that are typically found in cell surface molecules with adhesive functions. Predictive structural analysis of the shared receptor and fibronectin domains locates seven beta-strands in conserved regions of the chain; these strands are modeled to fold into antiparallel beta-sandwiches with a topology that is similar to immunoglobulin constant domains. These findings have strong implications for understanding the evolutionary emergence of an important class of regulatory molecules from primitive adhesive modules. In addition, the resulting double-barrel design of the receptors and the spatial clustering of conserved residues suggest a likely binding site for cytokine ligands.

Citing Articles

Based on the immune system: the role of the IL-2 family in pancreatic disease.

Zhu Y, Lu Z, Wang Z, Liu J, Ning K Front Immunol. 2025; 16:1480496.

PMID: 39958351 PMC: 11825815. DOI: 10.3389/fimmu.2025.1480496.


The JAK-STAT pathway: from structural biology to cytokine engineering.

Lv Y, Qi J, Babon J, Cao L, Fan G, Lang J Signal Transduct Target Ther. 2024; 9(1):221.

PMID: 39169031 PMC: 11339341. DOI: 10.1038/s41392-024-01934-w.


Designing monomeric IFNγ: The significance of domain-swapped dimer structure in IFNγ immune responses.

Goto Y, Miyafusa T, Honda S J Biol Chem. 2024; 300(7):107464.

PMID: 38879015 PMC: 11284706. DOI: 10.1016/j.jbc.2024.107464.


Compound heterozygous variants in MYBPC1 lead to severe distal arthrogryposis type-1 manifestations.

Iyer A, Lauerova B, Mariano J, Haberlova J, Lassuthova P, Zidkova J Gene. 2024; 910:148339.

PMID: 38438057 PMC: 10981553. DOI: 10.1016/j.gene.2024.148339.


Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.

Tomasovic L, Liu K, VanDyke D, Fabilane C, Spangler J BioDrugs. 2023; 38(2):227-248.

PMID: 37999893 PMC: 10947368. DOI: 10.1007/s40259-023-00635-0.


References
1.
Bazan J . A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem Biophys Res Commun. 1989; 164(2):788-95. DOI: 10.1016/0006-291x(89)91528-3. View

2.
Howell R, Rezvan H . Circular dichroic, infrared and other studies on the protein component of pig brain thromboplastin. Biochem J. 1980; 189(2):209-18. PMC: 1161991. DOI: 10.1042/bj1890209. View

3.
Miedel M, Hulmes J, Pan Y . Limited proteolysis of recombinant human soluble interleukin-2 receptor. Identification of an interleukin-2 binding core. J Biol Chem. 1989; 264(35):21097-105. View

4.
Boutin J, Edery M, Shirota M, Jolicoeur C, Lesueur L, Ali S . Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol Endocrinol. 1989; 3(9):1455-61. DOI: 10.1210/mend-3-9-1455. View

5.
Garnier J, Osguthorpe D, Robson B . Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 1978; 120(1):97-120. DOI: 10.1016/0022-2836(78)90297-8. View